Executive Vice President of $CRUS Sells 11,089 Shares in Insider Sale

In a recent development, the Executive Vice President (EVP) of $CRUS, Scott Thomas, has divested himself of 11,089 shares of the company on 09-18-2025, fetching an estimated $1,347,202. This transaction, revealed through a recent SEC filing, involved the sale of approximately 29.7% of Thomas’s holdings of this specific class of stock, leaving him with a remaining 26,307 shares of $CRUS stock in his possession.

Over the past six months, $CRUS insiders have engaged in active trading on the open market, conducting a total of 13 transactions. These transactions comprised solely sales, with zero purchases recorded during this period. From amongst the key insiders at $CRUS, notable sell-offs besides Scott Thomas’s recent activity include EVP of R&D Jeffrey W Baumgartner, who has undertaken 5 sales offloading 29,162 shares worth an estimated $3,217,251. Furthermore, EVP of Global Operations Justin E Dougherty has conducted 2 sales amounting to 5,380 shares valued at $550,902, with EVP of CHRO Denise Grode selling 4,410 shares worth $509,857 in two separate transactions. EVP of MSP Carl Jackson Alberty has similarly divested 4,000 shares for $400,700 across 2 sales, while Alexander M Davern sold 1,000 shares for $105,625.

On the institutional front, $CRUS saw 276 institutional investors augment their holdings of the company’s stock in the most recent quarter, while 244 reduced their positions. Notable movements in institutional holdings during this period include Ameriprise Financial Inc shedding 514,252 shares (-46.0%) valued at $53,613,342, Jones Financial Companies LLLP jettisoning 505,985 shares (-99.9%) worth $52,751,466, and Macquarie Group Ltd selling 452,296 shares (-96.8%) for $47,154,119.

Financial experts on Wall Street have been quite vocal about $CRUS in recent months, with 1 firm issuing buy ratings on the stock. A recent report from Stifel dated 09/12/2025 reiterated a “Buy” rating on $CRUS, aligning with positive sentiment surrounding the company. Analysts have also furnished price targets for $CRUS, with the median target standing at $110.0 across 2 analysts who have provided price guidance. For instance, Tore Svanberg from Stifel set a target price of $130.0 on 09/12/2025, while Tom O’Malley from Barclays offered a target price of $90.0 on 05/07/2025.

It is essential to note that the information provided in this article does not constitute financial advice and readers are encouraged to refer to Quiver Quantitative’s disclaimers for further clarification. Tracking insider transactions and hedge fund activities can offer valuable insights into market movements and investor sentiment, with tools like Quiver Quantitative’s insider trading dashboard and institutional holdings dashboard serving as useful resources for monitoring such activities related to companies like $CRUS.